Skip to main content
. 2024 Sep 6;147(12):4026–4032. doi: 10.1093/brain/awae288

Table 1.

Participant characteristics

ALS participants PLS participants Controls Total
Number of participants (female/male) 18 (8/10) 5 (2/3) 22 (12/10) 45 (23/22)
Age, mean (SD) 57.6 (11.7) 58.8 (2.6) 56.6 (8.8) 57.3 (9.6)
Limb onset: bulbar onset (for ALS cases) 15:3
ALSFRS-R score, mean (SD) 34.53 (7.5) 34.40 (3.2) N/A N/A
Estimated progression rate (ALSFRS-R point loss per month), mean (SD) 0.52 (0.37) 0.25 (0.14) N/A N/A
Disease duration in months from symptom onset, mean (SD) 37.4 (27.0) 86.9 (79.4) N/A N/A

ALS = amyotrophic lateral sclerosis; ALSFRS-R = ALS Functional Rating Scale-Revised; PLS = primary lateral sclerosis; SD = standard deviation.